Global stem cell testing market expected to reach $4.5

Dublin, July 06, 2022 (GLOBE NEWSWIRE) — The “stem cell testing market by type (viability, proliferation, differentiation, apoptosis), cell type (mesenchymal, iPSC, HSC, hESC), product and service (instrument), application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027″ report has been added to from offer.

The stem cell analysis market is expected to reach USD 4.5 billion by 2027, from USD 1.9 billion in 2022, at a CAGR of 17.7% during the forecast period.

The market growth is expected to be driven by collaborations and agreements among market players for stem cell assay products and services, launch of new stem cell analysis systems such as flow cytometers and increase R&D expenditure by biopharmaceutical and biotechnology companies.

Viability/cytotoxicity testing accounted for the largest share of the type segment in the stem cell testing market in 2021

Cell viability tests help determine the number of live and dead cells in a culture medium. Viability/cytotoxicity assays include various types such as tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, and other viability/cytotoxicity assays. The cell viability/cytotoxicity market is likely to be driven by increasing R&D spending in stem cell research, an increase in demand for stem cell testing in drug discovery and development of new stem cell therapies.

The adult stem cell segment accounted for the largest share of the cell type segment in the stem cell testing market in 2021.

Adult stem cells account for the largest share of the stem cell testing market. Adult stem cells include mesenchymal stem cells, induced pluripotent stem cells, hematopoietic stem cells, umbilical cord stem cells, and neural stem cells. The growth of the adult stem cell segment is driven by the increasing use of adult stem cells in regenerative medicine and the development of advanced therapies.

Asia-Pacific: The Fastest Growing Region in the Stem Cell Testing Market

Asia-Pacific is estimated to be the fastest growing segment of the market, owing to the increasing prevalence of cancer and other diseases, increasing R&D spending on biopharmaceutical projects and the focus on the development of stem cell therapies. In this region, China and Japan are the largest markets.

Main topics covered:

1. Introduction

2 Research methodology

3 Executive Summary

4 premium previews
4.1 Stem Cell Testing Market Overview
4.2 North America Stem Cell Testing Market, by Product, Service and Country (2021)
4.3 Stem Cell Testing Market Share, by Type, 2022 vs. 2027
4.4 Stem Cell Testing Market Share, by Application, 2021
4.5 Stem Cell Testing Market: Geographic Growth Opportunities

5 Market Overview
5.1 Presentation
5.2 Market Dynamics
5.2.1 Drivers Increase awareness of the therapeutic efficacy of stem cells Increase funding for stem cell research Growing Demand for Cellular Assays in Drug Discovery Collaborations and Agreements Among Market Players for Stem Cell Testing Products and Services Increase in cancer incidence
5.2.2 Constraints Challenges of research on embryonic stem cells High cost of stem cell analysis instruments
5.2.3 Opportunities Emerging economies Government initiatives to stimulate stem cell research
5.2.4 Challenges Lack of infrastructure for stem cell research in emerging economies Shortage of trained and qualified professionals
5.3 Ranges/scenarios
5.4 Impact of COVID-19 on Stem Cell Testing Market
5.5 Trends/disruptions affecting customer business
5.6 Price Analysis
5.6.1 Average Selling Prices of Products Offered by Major Players
5.6.2 Average selling price trend
5.7 Technology Analysis

6 Stem Cell Testing Market, by Type
6.1 Presentation
6.2 Viability/cytotoxicity assays
6.3 Isolation and purification tests
6.4 Cell identification assays
6.5 Proliferation tests
6.6 Differentiation tests
6.7 Function tests
6.8 Apoptosis assays

7 Stem Cell Testing Market, By Cell Type
7.1 Presentation
7.2 Adult stem cells
7.3 Human embryonic stem cells

8 Stem Cell Testing Market, By Product and Service
8.1 Presentation
8.2 Instruments
8.3 Sets
8.4 Services

9 Stem Cell Testing Market, by Application
9.1 Presentation
9.2 Development of regenerative medicine and therapy
9.3 Drug discovery and development
9.4 Clinical research

10 Stem Cell Testing Market, By End User

11 Stem Cell Testing Market, by Region

12 Competitive Landscape

13 company profiles

Companies cited

  • Aat Bioquest, Inc.
  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton, Dickinson and company
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • biotium
  • Bps Bioscience, Inc.
  • Cell Biolabs, Inc.
  • Charles River Laboratories
  • Creative bioarray
  • Danaher
  • Enzo Biochemistry Inc.
  • Fujifilm Holding Corporation
  • Geno Technology Inc
  • Hemogenix Inc
  • Lonza Group
  • Merk KGaA
  • Miltenyi Biotec
  • Perkinelmer Inc.
  • Promega Corporation
  • Promocell GmbH
  • Reachbio research laboratories
  • Stem cell technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

For more information about this report visit

  • Global Stem Cell Testing Market


Comments are closed.